VANGUARD THERAPEUTICS, INC.
Biotech · Private
Oral small-molecule therapeutic targeting P-selectin to improve microvascular blood flow in sickle cell disease
- Grants
- $5.4M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Reliable Assays for Pentosan Polysulfate Sodium | $109,280 | |
| Federal grant | Department of Health and Human Services · Phase II · Improved Oral P-selectin Blocker for Prophylactic Sickle Cell Disease Therapy | $1,668,155 | |
| Federal grant | Department of Health and Human Services · Phase II · Improved Oral P selectin Blocker for Prophylactic Sickle Cell Disease Therapy | $1,992,324 | |
| Federal grant | Department of Health and Human Services · Phase II · Improved Oral P-selectin Blocker for Prophylactic Sickle Cell Disease Therapy | $1,675,225 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3351 | PRIMORDIAL GENETICS, INC. | — | $1.6M |
| 3352 | RADIA TECHNICAL IMAGING LLC | — | $37K |
| 3353 | INFINITE ENERGY LLC | — | — |
| 3354 | VANGUARD THERAPEUTICS, INC. | — | — |
| 3355 | enGene Holdings | — | — |
| 3356 | Med Aditus Pharmaceuticals, Inc. | — | $5.0M |
| 3357 | CHRONUS PHARMACEUTICALS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Pentosan Polysulfate Sodium For The Treatment Of Sickle Cell Diseaseapplication
- Pentosan Polysulfate Sodium For The Treatment Of Sickle Cell Diseaseapplication
- Pentosan Polysulfate Sodium For The Treatment Of Sickle Cell Diseaseapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.